Holen Sie sich die Stockscreener-App
2.175
1.58%
-0.035
Schlusskurs vom Vortag:
$2.21
Offen:
$2.21
24-Stunden-Volumen:
19,910
Relative Volume:
0.01
Marktkapitalisierung:
$7.45M
Einnahmen:
$3.57M
Nettoeinkommen (Verlust:
$-15.74M
KGV:
-0.313
EPS:
-6.9481
Netto-Cashflow:
$-15.77M
1W Leistung:
-3.76%
1M Leistung:
-29.38%
6M Leistung:
-88.17%
1J Leistung:
-92.96%
1-Tages-Spanne:
$2.12
$2.21
1-Wochen-Bereich:
$2.12
$2.27
52-Wochen-Spanne:
$2.12
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Firmenname
Icecure Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare ICCM vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
2.175 | 7.57M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
106.12 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.88 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.78 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.62 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.54 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten
IceCure Medical Ltd. (ICCM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Icecure Medical Earnings Call Signals Early Growth Phase - TipRanks
IceCure (ICCM) Results at a Glance: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings: Shares Move 6.58% Down in Latest TradingTax Rate Impact - vinanet.vn
Icecure Medical Ltd. Signs Exclusive Distribution Agreement with Scovas Medical for Prosense Cryoablation Systems in the Netherlands - marketscreener.com
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands - PR Newswire
IceCure Medical (ICCM): Commercial Adoption Is Improving, but the Reimbursement and Scale Story Still Needs More Proof - AlphaStreet
ICCM Looks 87.8% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
IceCure says West Cancer Center IRB clears ChoICE breast cancer cryoablation study - Bitget
IceCure's ProSense Is First and Only for Low-Risk Breast Cancer With FDA Marketing Authorization - Stock Titan
Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: R - GuruFocus
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript - AOL.ca
IceCure (ICCM) Earnings Report: EPS Misses Its Estimate under the Current Snapshot; Share Response - vinanet.vn
IceCure Medical Ltd. SEC Filing (Aug 19, 2026) - Stock Titan
IceCure Medical (ICCM) grants 131K RSUs to North America VP - Stock Titan
IceCure Medical : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
IceCure Medical (NASDAQ: ICCM) director lists no shares - Stock Titan
IceCure (NASDAQ: ICCM) VP now holds 106K shares and RSUs - Stock Titan
IceCure Medical (ICCM) awards COO 141K new RSUs - Stock Titan
IceCure Medical (NASDAQ: ICCM) adds 73,890 RSUs to VP HR stake - Stock Titan
IceCure Medical (ICCM) director Chan Vincent leaves board - Stock Titan
ICCM Looks 85.8% Undervalued on GF Value™ - GuruFocus
IceCure Medical (NASDAQ: ICCM) awards CFO 181K stock units at $0 - Stock Titan
IceCure Medical director David Salton files initial beneficial ownership statement - Bitget
IceCure Medical (ICCM) expands 2024 employee share incentive reserve - Stock Titan
Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control - Stock Titan
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
IceCure Medical (ICCM) Earnings Call zum 2. Quartal 2026: Umsatz im 1. Halbjahr steigt um 45 % - TradingKey
IceCure Medical (ICCM) details 324,802-share warrant issuance and $9.7M potential proceeds - Stock Titan
New studies highlight FDA-approved ProSense cry... - pluang.com
Two papers examine tumor freezing beyond the primary breast tumor - Stock Titan
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation - PR Newswire
IceCure Medical regains Nasdaq bid price compliance - scanx.trade
IceCure Medical Q2 2026 Earnings Call Transcript - MarketBeat
IceCure sees Brazil adoption rise after FDA clearance - scanx.trade
IceCure Medical Ltd Q2 2026 Earnings Call Summary - Yahoo Finance
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year - GuruFocus
Earnings call transcript: IceCure Medical misses Q2 2026 estimates as shares fall - Investing.com
Icecure Medical Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
IceCure net loss widens to USD 8.78 million in H1 FY26; revenue rises 45% to USD 1.82 million - Bitget
IceCure Medical (Nasdaq: ICCM) lifts H1 revenue 45% but burns cash - Stock Titan
IceCure First-Half 2026 Earnings: 45% Revenue Growth Comes With Wider Losses - TradingKey
IceCure's Active U.S. Install Base Grows About 70%; Cash $12M - Stock Titan
Icecure Medical Q2 Results: EPS beats estimate, sales miss - scanx.trade
IceCure Medical (ICCM) names David Salton to board as independent director - Stock Titan
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 (PR Newswire) - Aktiellt
Earnings To Watch: Icecure Medical Ltd (ICCM) Q2 2026 -- GF Value Sees 452% Upside - GuruFocus
IceCure Medical Shareholders Approve Special Meeting Agenda on August 6, 2026 - The Globe and Mail
IceCure Medical (ICCM) holders approve agenda after adjourned meeting - Stock Titan
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment - Morningstar
IceCure Medical to Report First Half 2026 Financial and Operatin - GuruFocus
IceCure Medical (ICCM) Slides 4.05% as Shares Test Key $2.93 SupportSocial Sentiment - vinanet.vn
Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):